190 related articles for article (PubMed ID: 14634747)
1. [Standard and experimental therapy of cutaneous T-cell lymphoma].
Beyeler M; Dummer R
Hautarzt; 2003 Dec; 54(12):1177-84. PubMed ID: 14634747
[TBL] [Abstract][Full Text] [Related]
2. Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Bohmeyer J; Stadler R; Kremer A; Nashan D; Muche M; Gellrich S; Luger T; Sterry W
J Dtsch Dermatol Ges; 2003 Oct; 1(10):785-9. PubMed ID: 16281814
[TBL] [Abstract][Full Text] [Related]
3. [New approach to the treatment of primary malignant non-Hodgkin's lymphoma of the stomach].
Korobko VB; Chernyĭ VA; Valetskiĭ VL; Rozumiĭ DA; Gunina LM
Klin Khir; 1996; (1):39-42. PubMed ID: 8768208
[No Abstract] [Full Text] [Related]
4. Cutaneous T cell lymphoma: update of treatment.
Zackheim HS
Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
[TBL] [Abstract][Full Text] [Related]
5. Optimal combination with PUVA: rationale and clinical trial update.
Stadler R
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):29-32. PubMed ID: 17474357
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
7. [Lymphomas of the skin].
Nagatani T; Baba N; Nakajima H
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1308-13. PubMed ID: 7688500
[TBL] [Abstract][Full Text] [Related]
8. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Sheehy O; Catherwood M; Pettengell R; Morris TC
Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
[No Abstract] [Full Text] [Related]
9. Management of refractory early-stage cutaneous T-cell lymphoma.
Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous T cell lymphoma: current status and future directions.
Apisarnthanarax N; Talpur R; Duvic M
Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
[TBL] [Abstract][Full Text] [Related]
11. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
12. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
[TBL] [Abstract][Full Text] [Related]
14. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy.
French LE; Shapiro M; Junkins-Hopkins JM; Vittorio CC; Rook AH
J Am Acad Dermatol; 2001 Dec; 45(6):914-8. PubMed ID: 11712039
[TBL] [Abstract][Full Text] [Related]
15. [Principles of treatment and military medical examination of the patients with indolent Non-Hodgkin's lymphomas].
Seriakov AP; Ushakov II; Ardashev VN; Mazurov VI; Korotkiĭ AN
Voen Med Zh; 2003 Oct; 324(10):34-41, 96. PubMed ID: 14671893
[TBL] [Abstract][Full Text] [Related]
16. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
17. Therapeutic approaches in cutaneous lymphoma.
Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
[TBL] [Abstract][Full Text] [Related]
18. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
Spaccarelli N; Rook AH
Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of combination therapies for mycosis fungoides.
Humme D; Nast A; Erdmann R; Vandersee S; Beyer M
Cancer Treat Rev; 2014 Sep; 40(8):927-33. PubMed ID: 24997678
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms.
McGinnis KS; Junkins-Hopkins JM; Crawford G; Shapiro M; Rook AH; Vittorio CC
J Am Acad Dermatol; 2004 Mar; 50(3):375-9. PubMed ID: 14988678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
